Bisphosphonate related osteonecrosis of the jaw: A case report

In recent years, bisphosphosonate related osteonecrosis of the jaw have generated great concern regarding increased number of occurrences of this side effect It is of paramount importance that every dentist approaches these patients with the necessary precautions to avoid further complications in the course of dental treatment. The goal of this report is to present a patient with BRONJ)Bisphosphosonate Related Osteonecrosis of the Jaw???) and review the most important details of the case. A 59 years old female was referred to department of oral and maxillofacial surgery with chief complaint of halitosis and infection at the site of dental extraction. She had a history of consuming alendronate, 80 mg daily during for 8 years. Jaw osteonecrosis accompanying oro-antral fistula has consequensced a dentoalveolar procedure in this area. She was treated by surgical approaches to remove necrotic bone and close soft tissue with the use of tissue expander and advancement flaps. After 30 months follow up there is not any problem with oral hard and soft tissues. With regard to this paper, it is paramount that we should consider the history of bisphosphonate consumption for prevention of BRONJ.